M&R Capital Management Inc Novavax Inc Transaction History
M&R Capital Management Inc
- $445 Million
- Q3 2024
Shares
3 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$128 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$96.8 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$91.1 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$62.9 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$47.3 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $639M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...